T Regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury

Hypertension

Volumn 57, Issue 3, 2011, Pages 469-476

  Barhoumi, Tlili ^a,c   Kasal, Daniel A ^a,d   Li, Melissa W ^a   Shbat, Layla ^a   Laurant, Pascal ^c   Neves, Mario F ^d   Paradis, Pierre ^a   Schiffrin, Ernesto L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF AVIGNON   (France)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

blood pressure; cytokines; daptive immunity; endothelial dysfunction; inflammation; vascular remodeling

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL INJURY; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HEART; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYSTOLIC BLOOD PRESSURE;

ACETYLCHOLINE; ADAPTIVE IMMUNITY; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HYPERTENSION; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; VASCULAR CELL ADHESION MOLECULE-1; VASODILATOR AGENTS;

EID: 79953250615     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.162941     Document Type: Article

References (32)

1. Paradis P, Schiffrin EL. Renin-angiotensin-aldosterone system and pathobiology of hypertension. In: DeMello WC, Frohlich ED, eds. Renin Angiotensin System and Cardiovascular Disease. 2009:35-57.
2. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29:367-374.
3. Schiffrin EL. The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension. Hypertension. 2008;52:205-206.
4. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol. 2010;10:203-207.
5. Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension. 2009;54:439-443.
6. Schiffrin EL. T lymphocytes: a role in hypertension? Curr Opin Nephrol Hypertens. 2010;19:181-186.
7. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension. 2003;42:31-38. (Pubitemid 36842233)
8. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460. (Pubitemid 47529329)
9. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, Coffman TM. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1999;104:1693-1701. (Pubitemid 30053186)
10. Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol. 2007;18:1093-1102. (Pubitemid 46536895)
11. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, Harrison DG. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2009;296: R208-R216.
12. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol. 2009;123:735-746.
13. Sakaguchi S. Naturally arising Foxp3-expressing CD25-CD4- regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-352.
14. Valencia X, Lipsky PE. CD4-CD25-FoxP3- regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3:619-626.
15. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(-)CD25(-) T-cells from patients with type 1 diabetes. Diabetes. 2005;54:92-99.
16. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J. Role of naturally occurring CD4 CD25 regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:893-900. (Pubitemid 46606722)
17. Viel EC, Lemarié CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol. 2010;298:H938-H944.
18. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119:2904-2912.
19. Shi Y, Fukuoka M, Li G, Liu Y, Chen M, Konviser M, Chen X, Opavsky MA, Liu PP. Regulatory T cells protect mice against coxsackievirusinduced myocarditis through the transforming growth factor-coxsackieadenovirus receptor pathway. Circulation. 2010;121:2624-2634.
20. Leibovitz E, Ebrahimian T, Paradis P, Schiffrin EL. Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens. 2009;27:2192-2200.
21. Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol. 2010;134:33-46.
22. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colonystimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol. 2005;25:2106-2113. (Pubitemid 41416308)
23. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol. 2004;5:818-827. (Pubitemid 39172975)
24. Yanagitani Y, Rakugi H, Okamura A, Moriguchi K, Takiuchi S, Ohishi M, Suzuki K, Higaki J, Ogihara T. Angiotensin II type 1 receptormediated peroxide production in human macrophages. Hypertension. 1999;33:335-339. (Pubitemid 29065681)
25. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens. 2005; 14:125-131. (Pubitemid 40396865)
26. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 1999;100:2267-2275.
27. Rehman A, Ismail SB, Naing L, Roshan TM, Rahman AR. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition: a comparative study among malay hypertensive subjects with a known genetic profile. Am J Hypertens. 2007;20:184-189. (Pubitemid 46150021)
28. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112:2193-2200. (Pubitemid 41475815)
29. Mahadik SR, Deo SS, Mehtalia SD. Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects. Metab Syndr Relat Disord. 2008;6:121-128. (Pubitemid 351769259)
30. Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46:2018-2021. (Pubitemid 41713585)
31. Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, Hara Y, Shigematsu Y, Hiwada K. Effect of-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;37:412-417.
32. Guyton AC. Renal function curve-a key to understanding the pathogenesis of hypertension. Hypertension. 1987;10:1-6. (Pubitemid 17104004)